Clinical Trials Browser

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT02856347 2025-11-18

CMTpostopFDOPA

Phase NA Completed

24 enrolled

Carcinoma, Medullary

NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Phase NA Active not recruiting

20 enrolled 8 charts

BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT07138716 2025-08-24

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

Phase NA Recruiting

30 enrolled

Carcinoma, Medullary

NCT05534594 2025-06-24

MIMETIC

Phase NA Completed

8 enrolled

EndocrineHead & Neck

Thyroid cancer, medullary, Thyroid Neoplasms, Carcinoma, Medullary

NCT04522570 2025-04-30

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Phase NA Active not recruiting

84 enrolled

Head & Neck

Lymphatic Metastasis, Thyroid Neoplasms, Carcinoma, Medullary

NCT02592356 2024-03-05

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Phase NA Completed

23 enrolled

CNSEndocrine

Paraganglioma, Extra-Adrenal, Carcinoma, Medullary

NCT06277180 2024-02-26

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

Phase NA Recruiting

50 enrolled

Carcinoma, Medullary

NCT02363647 2022-08-31

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Phase NA Terminated

10 enrolled

GastrointestinalHead & Neck

Colonic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary

NCT03636945 2018-08-17

TEPCMT

Phase NA Unknown

62 enrolled

Carcinoma, Medullary

NCT00416949 2018-07-18

Iodine I 131 in Treating Patients With Thyroid Cancer

Phase NA Terminated

9 enrolled 4 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase NA Completed

40 enrolled

CNSEndocrineHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Clinical Trials

Cancer and Blood Pressure Management, CARISMA Study

CMTpostopFDOPA

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC

MIMETIC

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

TEPCMT

Iodine I 131 in Treating Patients With Thyroid Cancer

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer